• 1
    Steinberg AD, Kaltreider HB, Staples PJ, Goetzl EJ, Talal N, Decker JL: Cyclophosphamide in lupus nephritis: a controlled trial. Ann Intern Med 75: 165171, 1971
  • 2
    Sztejnbok M, Stewart A, Diamond H, Kaplan D: Azathioprine in the treatment of systemic lupus erythematosus: a controlled study. Arthritis Rheum 14: 639645, 1971
  • 3
    Donadio JV Jr, Holley KE, Wagoner RD, Ferguson RH, McDuffie FC: Treatment of lupus nephritis with prednisone and combine prednisone and azathioprine. Ann Intern Med 77: 829835, 1972
  • 4
    Cade R, Spooner G, Schlein E, Pickering M, de Quesada A, Holcomb A, Juncos L, Richard G, Shires D, Levin D, Hackett R, Free J, Hunt R, Fregly M: Comparison of azathioprine, prednisone, and heparin alone or combined in treating lupus nephritis. Nephron 10: 3756, 1973
  • 5
    Donadio JV Jr, Holley KE, Wagoner RD, Ferguson RH, McDuffie FC: Further observations on the treatment of lupus nephritis with prednisone and combined prednisone and azathioprine. Arthritis Rheum 17: 573581, 1974
  • 6
    Hahn BH, Kantor OS, Osterland CK: Azathioprine plus prednisone compared with prednisone alone in the treatment of systemic lupus erythematosus: report of a prospective controlled trial in 24 patients. Ann Intern Med 83: 597605, 1975
  • 7
    Donadio J Jr, Holley KE, Ferguson RH, Ilstrup DM. Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide. N Engl J Med 299: 11511155, 1978
  • 8
    Steinberg AD, Plotz PH, Wolff SM, Wong VG, Agus SG, Decker JD: Cytotoxic drugs in treatment on non-malignant diseases. Ann Intern Med 76: 619642, 1972
  • 9
    Steinberg AD, Gelfand MC, Hardin JA, Lowenthal DT: Therapeutic studies in NZB/W mice. III. Relationship between renal status and efficacy of immunosuppressive drug therapy. Arthritis Rheum 18: 914, 1975
  • 10
    Steinberg AD, Decker JL: A double-blind controlled trial comparing cyclophosphamide, azathioprine and placebo in the treatment of lupus glomerulonephritis. Arthritis Rheum 17: 923937, 1974
  • 11
    Decker JL, Klippel JH, Plotz PH, Steinberg AD: Cyclophosphamide or azathioprine in lupus glomerulonephritis: a controlled trial: results at 28 months. Ann Intern Med 83: 606615, 1975
  • 12
    Dinant HJ, Decker JL, Klippel JH, Balow JE, Plotz PH, Steinberg AD: Alternative modes of cyclophosphamide and azathioprine therapy in lupus nephritis. Ann Intern Med 96: 728736, 1982
  • 13
    Carette S, Klippel JH, Decker JL, Austin HA, Plotz PH, Steinberg AD, Balow JE: Controlled studies of oral immunosuppressive drugs in lupus nephritis: a long-term follow-up. Ann Intern Med 99: 18, 1983
  • 14
    Austin HA, Klippel JH, Balow JE, LeRiche NG, Steinberg AD, Plotz PH, Decker JL: Therapy of lupus nephritis: controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314: 614619, 1986
  • 15
    Cohen AS, Reynolds WE, Franklin EC, Kulka JP, Ropes MW, Shulman LE, Wallace SL: Preliminary criteria for the classification of systemic lupus erythematosus. Bull Rheum Dis 21: 643648, 1971
  • 16
    Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457481, 1958
  • 17
    Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163170, 1966
  • 18
    Benedetti J, Yuen K, Young L: Life tables and survival functions, BMDP Statistical Software. Edited by WJDixon. Berkeley, University of California Press, 1981
  • 19
    Austin HA III, Muenz LR, Joyce KM, Balow JE: Prognostic factors in lupus nephritis: contribution of renal histologic data. Am J Med 75: 382391, 1983
  • 20
    Elliot RW, Essenhigh DM, Morley AR: Cyclophosphamide treatment of systemic lupus erythematosus: risk of bladder cancer exceeds benefit. Br Med J 284: 11601161, 1982
  • 21
    Gibbons RB, Westerman E: Acute nonlymphocytic leukemia following short-term, intermittent, intravenous cyclophosphamide treatment of lupus nephritis. Arthritis Rheum 31: 15521554, 1988
  • 22
    Felson DT, Anderson J: Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis: results of a pooled analysis. N Engl J Med 311: 15281533, 1984
  • 23
    Cathcart ES, Idelson BA, Scheinberg MA, Couser WG: Beneficial effects of methylprednisolone “pulse” therapy in diffuse proliferative lupus nephritis. Lancet I: 163166, 1976
  • 24
    Strober S, Fariñas MC, Field EH, Solovera JJ, Kiberd BA, Myers BD, Hoppe RT: Treatment of lupus nephritis with total lymphoid irradiation: observations during a 12–79-month followup. Arthritis Rheum 31: 850858, 1988
  • 25
    Chagnac A, Kiberd BA, Fariñas C, Strober S, Sibley RK, Hoppe R, Myers BD: Outcome of the acute glomerular injury in proliferative lupus nephritis. J Clin Invest 84: 922930, 1989